Showing results (11-20 of 22) with videos related to
Sort By:
Pageof 3
Cancer Discovery|February 20, 2019
BCL6 Evolved to Enable Stress Tolerance in Vertebrates and Is Broadly Required by Cancer Cells to Adapt to StressTharu M Fernando, Rossella Marullo, Benet Pera Gresely, et al.The Journal of Clinical Investigation|November 3, 2010
BCL6 repression of EP300 in human diffuse large B cell lymphoma cells provides a basis for rational combinatorial therapyLeandro C Cerchietti, Katerina Hatzi, Eloisi Caldas-Lopes, et al.Blood|December 10, 2014
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cellsFlorencia Cayrol, María Celeste Díaz Flaqué, Tharu Fernando, et al.Cancer Cell|December 15, 2012
MALT1 small molecule inhibitors specifically suppress ABC-DLBCL in vitro and in vivoLorena Fontan, Chenghua Yang, Venkataraman Kabaleeswaran, et al.Nature Communications|January 31, 2017
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitorsFlorencia Cayrol, Pannee Praditsuktavorn, Tharu M Fernando, et al.Cancer Cell|April 14, 2010
A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivoLeandro C Cerchietti, Alexandru F Ghetu, Xiao Zhu, et al.Blood|August 11, 2011
DNA methyltransferase 1 and DNA methylation patterning contribute to germinal center B-cell differentiationRita Shaknovich, Leandro Cerchietti, Lucas Tsikitas, et al.Cancer Research|September 4, 2021
Oncogenic HSP90 Facilitates Metabolic Alterations in Aggressive B-cell LymphomasM Nieves Calvo-Vidal, Nahuel Zamponi, Jan Krumsiek, et al.Cancer Discovery|February 25, 2017
BCL6 Antagonizes NOTCH2 to Maintain Survival of Human Follicular Lymphoma CellsEster Valls, Camille Lobry, Huimin Geng, et al.The Journal of Clinical Investigation|August 3, 2016
Rationally designed BCL6 inhibitors target activated B cell diffuse large B cell lymphomaMariano G Cardenas, Wenbo Yu, Wendy Beguelin, et al.Pageof 3